Perspective
Published on 22 Dec 2022
Addressing quality and safety in anatomic pathology in low- and middle-income countries
in Pathology
Frontiers in Medicine
doi 10.3389/fmed.2022.1060179
- 3,319 views
- 3 citations
- Frontiers in Medicine
- Pathology
- Articles
Type at least 3 characters
283 articles
Case Report
Published on 22 Dec 2022
Case report: BRAF-inhibitor therapy in BRAF-mutated primary CNS tumours including one case of BRAF-mutated Rosai-Dorfman disease
in Pathology
Frontiers in Medicine
doi 10.3389/fmed.2022.1070828
- 3,401 views
- 4 citations
Original Research
Published on 14 Dec 2022
Reliability of CD44, CD24, and ALDH1A1 immunohistochemical staining: Pathologist assessment compared to quantitative image analysis
in Pathology
Frontiers in Medicine
doi 10.3389/fmed.2022.1040061
- 3,987 views
- 15 citations
Original Research
Published on 07 Dec 2022
A mucosal recovery software tool for endoscopic submucosal dissection in early gastric cancer
in Pathology
Frontiers in Medicine
doi 10.3389/fmed.2022.1001383
- 2,058 views
Original Research
Published on 07 Dec 2022
A comparative study of gastric histopathology sub-size image classification: From linear regression to visual transformer
in Pathology
Frontiers in Medicine
doi 10.3389/fmed.2022.1072109
- 3,142 views
- 15 citations
Original Research
Published on 24 Nov 2022
Clinicopathologic and genomic characterizations of brain metastases using a comprehensive genomic panel
in Pathology
Frontiers in Medicine
doi 10.3389/fmed.2022.947456
- 2,748 views
- 3 citations
Original Research
Published on 10 Nov 2022
Short-term outcomes of near-infrared imaging using indocyanine green in laparoscopic lateral pelvic lymph node dissection for middle-lower rectal cancer: A propensity score-matched cohort analysis
in Pathology
Frontiers in Medicine
doi 10.3389/fmed.2022.1039928
- 1,751 views
- 15 citations
Case Report
Published on 08 Nov 2022
KMT2C mutation is a diagnostic molecular marker for primary thyroid osteosarcoma: A case report and literature review
in Pathology
Frontiers in Medicine
doi 10.3389/fmed.2022.1030888
- 2,484 views
- 6 citations
Case Report
Published on 08 Nov 2022
An extremely rare case of malignant jejunal mesenteric inflammatory myofibroblastic tumor in a 61-year-old male patient: A case report and literature review
in Pathology
Frontiers in Medicine
doi 10.3389/fmed.2022.1042262
- 3,451 views
- 6 citations
Original Research
Published on 08 Nov 2022
Clinicopathologic features of renal cell carcinomas seen at the Aga Khan University Hospital in Kenya
in Pathology
Frontiers in Medicine
doi 10.3389/fmed.2022.981305
- 2,809 views
- 3 citations
Systematic Review
Published on 07 Nov 2022
MicroRNA panels as diagnostic biomarkers for colorectal cancer: A systematic review and meta-analysis
in Pathology
Frontiers in Medicine
doi 10.3389/fmed.2022.915226
- 6,600 views
- 29 citations
Original Research
Published on 26 Oct 2022
Disturbed natural killer cell homeostasis in the salivary gland enhances autoimmune pathology via IFN-γ in a mouse model of primary Sjögren’s syndrome
in Pathology
Frontiers in Medicine
doi 10.3389/fmed.2022.1036787
- 3,681 views
- 12 citations
Original Research
Published on 26 Oct 2022
Adipositas and metabolic bone disorder in a 16th century Upper Austrian infant crypt mummy—An interdisciplinary palaeopathological insight into historical aristocratic life
in Pathology
Frontiers in Medicine
doi 10.3389/fmed.2022.979670
- 76,713 views
- 4 citations
Original Research
Published on 24 Oct 2022
Development of combinatorial antibody therapies for diffuse large B cell lymphoma
in Pathology
Frontiers in Medicine
doi 10.3389/fmed.2022.1034594
- 3,292 views
- 1 citation
Original Research
Published on 21 Oct 2022
Harnessing artificial intelligence to infer novel spatial biomarkers for the diagnosis of eosinophilic esophagitis
in Pathology
Frontiers in Medicine
doi 10.3389/fmed.2022.950728
- 4,107 views
- 22 citations
![A new small molecule DHODH-inhibitor [KIO-100 (PP-001)] targeting activated T cells for intraocular treatment of uveitis — A phase I clinical trial](https://www.frontiersin.org/files/myhome article library/1023224/1023224_Thumb_400.jpg)
Clinical Trial
Published on 17 Oct 2022
A new small molecule DHODH-inhibitor [KIO-100 (PP-001)] targeting activated T cells for intraocular treatment of uveitis — A phase I clinical trial
in Pathology
Frontiers in Medicine
doi 10.3389/fmed.2022.1023224
- 4,624 views
- 1 citation